nib Holdings (NHF) – NEUTRAL
|Date of Report||ASX||Price||Price Target||Analyst Recommendation|
|Date of Report|
|Sector : Financials||52-Week Range: A5.13 – 7.2|
|Industry: Life and Health Insurance||Market Cap: A$2,997.5m|
We rate NHF as a Neutral for the following reasons:
- Softer management FY19 outlook.
- Given Australia’s growing and ageing population, there will be increased demand for health care services. This will add additional pressure on Australia’s public health care system and the Federal budget and an increased dependence on private health care insurers. NHF offers exposure to the business model of providing a funding mechanism for the high-growth health care sector. Healthcare spending is expected to grow at 5-10% per annum, so without significant tax hikes, the government cannot afford for people to shift back to the public healthcare system.
- Given underlying increases in average premium rates of around 5 – 6% p.a., some policyholder growth (especially at the 30-34-year-old segment), and exposure to upstart investments, we estimate that NHF offers close to double-digit underlying growth in the medium term.
- Solid management team, with an impressive 10-year average combined operating ratio of ~90-95% and strong ~25% ROEs.
- Cost-out strategy which improves the company’s expense ratio.
- Incentives and benefits encourage PHI take-up. They include 1. Tax benefits and penalties for Australian residents (via Lifetime Health Cover, Medicare Levy Surcharge and means tested rebate); and 2. Shorter wait times, a choice of specialist doctor/hospital and coverage of ancillary health services support.
- Growth runways through the JV with Tasly Holdings Group, and also international expansion, through product offerings like NISS.
We see the following key risks to our investment thesis:
- Intensifying competition between top 6 players, putting policy growth targets at risk and any Increases in expected marketing spend going forward will no doubt add further strain on earnings growth.
- Policyholders decline declines unexpectedly despite the encouraging incentives and Australian Government struggling with the rapid increase in healthcare spending and health services demand.
- Registered health insurers cannot increase premium rates without approval from the Government/Minister for Health/PHIAC/APRA. This leaves NHF’s ROE and margins exposed to a political process and pressures if the company is deemed too profitable.
- Regulatory changes especially relating to any changes to tax incentives and benefits which encourage take up of PHI.
- Higher than expected lapse rates and claims inflation as a result of poor insurance policy design, aging population, and costs of new medical equipment, procedures and treatments;
- Poor negotiations with healthcare providers such as private hospital operators leading to unfavourable contractual terms;
- Lower than expected investment returns.
Figure 1: Revenue by segment
nib Holdings Limited (NHF) announced FY18 results delivering underlying operating profit (UOP) of $184.8m, an increase of +20.2% on the pcp. Net profit after tax (NPAT) grew +11.1% to $133.5m but missed analyst estimate of $135m which saw NHF’s share price slide by -1.8%.
Statutory earnings per share were up by +8.0% to 29.4cps. Management declared a final dividend of 11cps, increasing the full year dividend for FY18 to 20cps (fully franked), representing a gain of +5.3% on payout ratio of 68.5%.
We see nib as having attractive growth avenues through their current JV with Tasly, which would provide an opportunity to sell health insurance in China, however increasing regulatory scrutiny and difficult market conditions in Australia and NZ are likely to have a negative impact on margins and profits in the short term (whilst the long-term investment thesis remains intact). Trading on PE-multiple of 19.7x and yield of 3.2% – maintain Neutral.
- FY19 Guidance.
1. nib anticipates a group UOP of ~$180m and statutory operating profit of ~$159m for FY19.
2. Market conditions in Australian and New Zealand market are expected to be difficult and continue to be affected by macroeconomic factors including affordability and negligible growth in discretionary spending.
3. Arhi segment is expected to deliver organic growth of +3%-4% but management anticipates net margin contraction from 6.9% in FY18 to 5%-6% in FY19. Management expects Federal Opposition’s premium cap proposal to put additional pressure on arhi’s net margins from FY21.
4. nib expects to start selling health insurance in China in collaboration with its JV partner Tasly in 2H19 (subject to regulatory approval).
5. Management noted, “nib is confident that it can navigate its way to meet any additional requirements for regulatory capital while acknowledging the uncertainty around the question.”
6. Management expects dividend payout ratio of 60-70% of NPAT for FY19.
- Australian Residents Health Insurance (arhi)-double digit earnings growth. Arhi business delivered strong growth with premium revenue up +12.1% to $1.9bn (of which +6.5% growth was attributable to GU Health acquisition) and UOP up +22.1% to $130.7m driven by strong organic growth and acquisition of GU Health. Net margin grew by 50bps to 6.9%, driven by lower than expected claims growth (reduction in medical prosthetics claims).
- International students and workers. nib’s international students and workers business revenue increased +24.7% to $93.3m and UOP increased +16.5% to $29.6m while margins fell by 230bps to 31.7% due to intense price competition and integration of GU Health. NHF now covers ~160k international students and workers, and they aim to leverage existing capabilities by launching nib International Student Services (NISS), a service provider for international students beyond Australia which would be ready to make sales in FY19.
- World Nomads Group (WNG). Performed strong, delivering sales growth of +7.3%, with international sales up +16.5%. Gross written premium rose +7.7% to $142m, with UOP up +8.0% to $8.1m driven by international policy sales growth in U.S.
- New Zealand. nib New Zealand delivered a solid result despite the loss of a large corporate group client in 2H17, with the loss reflecting in premium revenue offset by policyholder growth in other channels and premium adjustments. While the business grew net policies by 2.8%, UOP was down slightly by 0.4% to $23.4m, negatively impacted by NZD/AUD exchange rates (on NZD basis the business grew premium revenue by +1.9% and UOP by +3.8%).
- QBE Travel insurance acquisition. Management announced acquisition of QBE Travel on 3 August 2018 for a total consideration of $25m (excluding integration costs of ~$11m) to be funded by existing available capital. Management noted that the acquisition would increase gross written premiums of World Nomads Group by +40% and would consolidate the business’ domestic market position.
NHF FY18 RESULTS SUMMARY…
Figure 3: NHF Financial Summary – by segments
Source: Company, BTIG, Bloomberg
Figure 4: FY19 Guidance Breakdown
Source: Company, BTIG, Bloomberg
Figure 5: Australian Insurance Comparable
Source: Company, BTIG, Bloomberg
Figure 6: NHF Financial Summary
Source: Company, BTIG, Bloomberg
nib Holdings Limited (NHF) is the Australian private health insurer. NHF operates in four divisions which are private health insurance, life insurance, travel insurance and related health care activities.
Recommendation Rating Guide
|Recommendation Rating Guide||Total Return Expectations on a 12-mth view|
|Speculative Buy||Greater than +30%|
|Buy||Greater than +10%|
|Neutral||Greater than 0%|
|Sell||Less than -10%|
Reach Markets Disclaimer
Reach Markets Pty Ltd (ABN 36 145 312 232) is a Corporate Authorised Representative of Reach Financial Group Pty Ltd (ABN 17 090 611 680) who holds Australian Financial Services Licence (AFSL) 333297. Please refer to our Financial Services Guide or you can request for a copy to be sent to you, by emailing email@example.com.
Read our full disclaimer here >
This publication contains general securities advice. In preparing the advice, Reach Markets Australia has not taken into account the investment objectives, financial situation and particular needs of any particular person. Before making an investment decision on the basis of this advice, you need to consider, with or without the assistance of a securities adviser, whether the advice in this publication is appropriate in light of your particular investment needs, objectives and financial situation. Reach Markets Australia and its associates within the meaning of the Corporations Act may hold securities in the companies referred to in this publication. Reach Markets Australia does, and seeks to do, business with companies that are the subject of its research reports. Reach Markets Australia believes that the advice and information herein is accurate and reliable, but no warranties of accuracy, reliability or completeness are given (except insofar as liability under any statute cannot be excluded). No responsibility for any errors or omissions or any negligence is accepted by Reach Markets Australia or any of its directors, employees or agents. This publication must not be distributed to retail investors outside of Australia.
It is recommended that you seek independent advice and read the relevant Product Disclosure Statement before making a decision in relation to any investment. Any advice contained in this communication is general and has not taken into account the investment objectives, financial situation and particular needs of any particular person.
Banyan Tree Disclaimer
This document is provided by Banyan Tree Investment Group (ACN 611 390 615; AFSL 486279) (“Banyan Tree”).
The material in this document may contain general advice or recommendations which, while believed to be accurate at the time of publication, are not appropriate for all persons or accounts. This document does not purport to contain all the information that a prospective investor may require. The material contained in this document does not take into consideration an investor’s objectives, financial situation or needs. Before acting on the advice, investors should consider the appropriateness of the advice, having regard to the investor’s objectives, financial situation and needs. The material contained in this document is for sales purposes. The material contained in this document is for information purposes only and is not an offer, solicitation or recommendation with respect to the subscription for, purchase or sale of securities or financial products and neither or anything in it shall form the basis of any contract or commitment. This document should not be regarded by recipients as a substitute for the exercise of their own judgment and recipients should seek independent advice.
The material in this document has been obtained from sources believed to be true but neither Banyan Tree nor its associates make any recommendation or warranty concerning the accuracy, or reliability or completeness of the information or the performance of the companies referred to in this document. Past performance is not indicative of future performance. Any opinions and or recommendations expressed in this material are subject to change without notice and Banyan Tree is not under any obligation to update or keep current the information contained herein. References made to third parties are based on information believed to be reliable but are not guaranteed as being accurate.
Banyan Tree and its respective officers may have an interest in the securities or derivatives of any entities referred to in this material. Banyan Tree does, and seeks to do, business with companies that are the subject of its research reports. The analyst(s) hereby certify that all the views expressed in this report accurately reflect their personal views about the subject investment theme and/or company securities.
Although every attempt has been made to verify the accuracy of the information contained in the document, liability for any errors or omissions (except any statutory liability which cannot be excluded) is specifically excluded by Banyan Tree, its associates, officers, directors, employees and agents. Except for any liability which cannot be excluded, Banyan Tree, its directors, employees and agents accept no liability or responsibility for any loss or damage of any kind, direct or indirect, arising out of the use of all or any part of this material. Recipients of this document agree in advance that Banyan Tree is not liable to recipients in any matters whatsoever otherwise recipients should disregard, destroy or delete this document. All information is correct at the time of publication. Banyan Tree does not guarantee reliability and accuracy of the material contained in this document and is not liable for any unintentional errors in the document.
The securities of any company(ies) mentioned in this document may not be eligible for sale in all jurisdictions or to all categories of investors. This document is provided to the recipient only and is not to be distributed to third parties without the prior consent of Banyan Tree.
This document has been commissioned by Reach Markets Australia Pty Ltd and provided by Banyan Tree Investment Group (ACN 611 390 615; AFSL 486279) (“Banyan Tree”).